Jacky Luiten

Trends in incidence and tumor grade in screen‐detected DCIS and invasive breast cancer | 29 2 References 1. Jing HYY, Wernick MN, Yarusso LM, Nishikawa RM. A comparison study of image features between FFDM and film mammogram images. Med Phys 2012;39(7):8. 2. Nederend J, Duijm LE, Voogd AC, Groenewoud JH, Jansen FH, Louwman MW. Trends in incidence and detection of advanced breast cancer at biennial screening mammography in The Netherlands: a population based study. Breast Cancer Res 2012;14(1):R10. 3. van Steenbergen LN, Voogd AC, Roukema JA, Louwman WJ, Duijm LE, Coebergh JW, van de Poll‐ Franse LV. Screening caused rising incidence rates of ductal carcinoma in situ of the breast. Breast Cancer Res Treat 2009;115(1):181–183. 4. Richtlijn mammacarinoom [Internet] Dutch breast cancer guideline. NABON. http://www.oncoline.nl/mammacarcinoom 5. Ernster VL, Ballard‐Barbash R, Barlow W E, Zheng Y, Weaver DL, Cutter G, Yankaskas BC, Rosenberg R, Carney PA, Kerlikowske K et al. Detection of ductal carcinoma in situ in women undergoing screening mammography. J Natl Cancer Inst 2002;94(20):1546–1554. 6. Hollingsworth A. Overestimating overdiagnosis in breast cancer screening. Cureus 2017;9(1):e966. 7. Yen MFTL, Vitak B, Smith RA, Chen HH, Duffy SW. Quantifying the potential problem of overdiagnosis of ductal carcinoma in situ in breast cancer screening. Eur J Cancer 2003;39(12):8. 8. Duffy SW, Agbaje O, Tabar L, Vitak B, Bjurstam N, Bjorneld L, Myles JP, Warwick J. Overdiagnosis and overtreatment of breast cancer: estimates of overdiagnosis from two trials of mammographic screening for breast cancer. Breast Cancer Res 2005;7(6):258–265. 9. Seigneurin A, Labarere J, Francois O, Exbrayat C, Dupouy M, Filippi M, Colonna M. Overdiagnosis and overtreatment associated with breast cancer mammography screening: a simulation study with calibration to population‐based data. Breast 2016;28:60–66. 10. Duijm LE, Groenewoud JH, Jansen FH, Fracheboud J, van Beek M, de Koning HJ. Mammography screening in the Netherlands: delay in the diagnosis of breast cancer after breast cancer screening. Br J Cancer 2004;91(10):1795–1799. 11. Setz‐Pels W, Duijm LE, Coebergh JW, Rutten M, Nederend J, Voogd AC. Re‐attendance after false‐ positive screening mammography: a population‐based study in the Netherlands. Br J Cancer 2013;109(8):20 44–2050. 12. Radiology AC: B reast Imaging Reporting and D ata System (BIRADS), 4th edn. American College of Radiology 2003. https://www.acr.org/Quality‐ Safety/Resources/BIRADS. 13. Sickles E, D’Ors i CJ, Bassett LW: ACR BI‐RA DS "  Mammography. ACR BI‐RADS "  Atlas, Breast Imaging Repo rting and Data System . American College of Radiology 2013. https://www.acr.org/Quality‐ Safety/Resources/BIRADS. 14. Cuzick J, Sestak I, Pinder SE, Ellis IO, Forsyth S, Bundred NJ, Forbes JF, Bishop H, Fentiman IS, George WD. Effect of tamoxife n and radiotherapy in women with locally excised ductal carcinoma in situ: long‐term results from the UK/ANZ DCIS trial. Lancet Oncol 2011;12(1):21–29. 15. Ellis IO. Intraductal proliferative lesions of the breast: morphology, associated risk and molecular biology. Mod Pathol 2010;23(Suppl 2):S1–S7. 16. Duffy SW, Dibden A, Michalopoulos D, Offman J, Parmar D, Jenkins J, Collins B, Robson T, Scorfield S, Green K et al. Screen detection of ductal carcinoma in situ and subsequent incidence of invasive interval breast cancers: a retrospective population‐based study. Lancet Oncol 2016;17(1): 109‐114. 17. Del Turco MR, Mantellini P, Ciatto S, Bonardi R, Martinelli F, Lazzari B, Houssami N. Full‐field digital versus screenfilm mammography: comparative accuracy in concurrent screening cohorts. Am J Roentgenol 2007;189(4):860–866. 18. Karssemeijer N, Bluekens AM, Beijerinck D, Deurenberg JJ, Beekman M, Visser R, van Engen R, Bartels‐Kortland A, Broeders MJ. Breast cancer screening results 5 years after introduction of digital mammography in a population‐based screening program. Radiology 2009;253(2):353–358.